All Stories

  1. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  2. Central nervous system Aspergillus quadrilineatus infection in a COVID‐19 patient, a case report and literature review
  3. Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment
  4. Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran
  5. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  6. Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains
  7. Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis
  8. Acknowledgment to the Reviewers of Journal of Fungi in 2022
  9. Acknowledgment to the Reviewers of Antibiotics in 2022
  10. Acknowledgment to the Reviewers of Life in 2022
  11. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice
  12. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs
  13. 2022 OFID Reviewer Recognition List
  14. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis
  15. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran
  16. P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis
  17. P285 Predominance of Trichophyton tonsurans causing tinea capitis: a 12-years retrospective study in north of Iran
  18. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling
  19. Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran
  20. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  21. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology
  22. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study
  23. 2021 OFID Reviewer Recognition List
  24. Antifungal Properties of Zataria multiflora on Candida species: A Systematic Review
  25. Acknowledgment of Reviewers 2021
  26. Acknowledgment of Reviewers 2021
  27. In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis
  28. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐center experience in Iran
  29. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice
  30. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis
  31. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran
  32. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects
  33. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  34. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
  35. Candida africana vulvovaginitis: Prevalence and geographical distribution
  36. Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis
  37. Cryptococcus and cryptococcosis in Iran during 1969–2019: A systematic review and meta-analysis
  38. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  39. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis
  40. Cover Image
  41. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  42. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends
  43. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  44. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism
  45. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples
  46. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  47. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review